Citi analyst Laura Sutcliffe maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$34.00. The company’s shares clos...
Citi analyst Laura Sutcliffe maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$34.00. The company’s shares clos...